These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16612755

  • 1. [Neurotrophic factor expression in vestibular schwannoma. An overview].
    Diensthuber M, Lenarz T, Stöver T.
    Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.
    Koutsimpelas D, Stripf T, Heinrich UR, Mann WJ, Brieger J.
    Otol Neurotol; 2007 Dec; 28(8):1094-9. PubMed ID: 17721409
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of transforming growth factor-beta1 and glial cell line-derived neurotrophic factor in vestibular schwannoma.
    Diensthuber M, Brandis A, Lenarz T, Stöver T.
    Otol Neurotol; 2004 May; 25(3):359-65. PubMed ID: 15129118
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
    Hung G, Colton J, Fisher L, Oppenheimer M, Faudoa R, Slattery W, Linthicum F.
    Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M, Ilner T, Rodt T, Samii M, Brandis A, Lenarz T, Stöver T.
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue.
    Taurone S, Bianchi E, Attanasio G, Di Gioia C, Ierinó R, Carubbi C, Galli D, Pastore FS, Giangaspero F, Filipo R, Zanza C, Artico M.
    Mol Med Rep; 2015 Jul; 12(1):737-45. PubMed ID: 25738867
    [Abstract] [Full Text] [Related]

  • 7. The molecular biology and novel treatments of vestibular schwannomas.
    Fong B, Barkhoudarian G, Pezeshkian P, Parsa AT, Gopen Q, Yang I.
    J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
    [Abstract] [Full Text] [Related]

  • 8. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL.
    BMC Neurosci; 2004 Oct 28; 5():41. PubMed ID: 15511288
    [Abstract] [Full Text] [Related]

  • 9. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.
    Stonecypher MS, Chaudhury AR, Byer SJ, Carroll SL.
    J Neuropathol Exp Neurol; 2006 Feb 28; 65(2):162-75. PubMed ID: 16462207
    [Abstract] [Full Text] [Related]

  • 10. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A.
    Oncogene; 2001 Jan 04; 20(1):97-105. PubMed ID: 11244508
    [Abstract] [Full Text] [Related]

  • 11. BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.
    Kramer F, Stöver T, Warnecke A, Diensthuber M, Lenarz T, Wissel K.
    J Neurooncol; 2010 May 04; 98(1):31-9. PubMed ID: 19937367
    [Abstract] [Full Text] [Related]

  • 12. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
    Lasak JM, Welling DB, Akhmametyeva EM, Salloum M, Chang LS.
    Laryngoscope; 2002 Sep 04; 112(9):1555-61. PubMed ID: 12352662
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG, Sun QF, Tirakotai W, Zhao WG, Shen JK, Luo QZ, Bertalanffy H.
    Chin Med J (Engl); 2005 Sep 20; 118(18):1517-24. PubMed ID: 16232328
    [Abstract] [Full Text] [Related]

  • 14. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.
    Am J Otol; 1997 Nov 20; 18(6):754-60. PubMed ID: 9391673
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta1 expression in human acoustic neuroma.
    Cardillo MR, Filipo R, Monini S, Aliotta N, Barbara M.
    Am J Otol; 1999 Jan 20; 20(1):65-8. PubMed ID: 9918175
    [Abstract] [Full Text] [Related]

  • 16. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
    Halum SL, Erbe CB, Friedland DR, Wackym PA.
    Otolaryngol Head Neck Surg; 2003 Mar 20; 128(3):364-71. PubMed ID: 12646839
    [Abstract] [Full Text] [Related]

  • 17. Expression of transforming growth factor-beta receptor type 1 and type 2 in human sporadic vestibular Schwannoma.
    Löttrich M, Mawrin C, Chamaon K, Kirches E, Dietzmann K, Freigang B.
    Pathol Res Pract; 2007 Mar 20; 203(4):245-9. PubMed ID: 17317032
    [Abstract] [Full Text] [Related]

  • 18. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R, Ramsden RT, Saeed SR, Aggarwal R, King AT, Rutherford SA, Evans DG, Gillespie JE.
    J Laryngol Otol; 2010 Mar 20; 124(3):251-7. PubMed ID: 20003606
    [Abstract] [Full Text] [Related]

  • 19. Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma.
    Dillard DG, Venkatraman G, Cohen C, Delgaudio J, Gal AA, Mattox DE.
    Acta Otolaryngol; 2001 Jan 20; 121(2):149-52. PubMed ID: 11349767
    [Abstract] [Full Text] [Related]

  • 20. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.
    Dilwali S, Roberts D, Stankovic KM.
    Cancer Biol Ther; 2015 Jan 20; 16(1):170-5. PubMed ID: 25692621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.